Gevo News and Activities

Gevo is a company listed under the stock ticker GEVO (US).

View the org chart displaying its 27 main executives

Most searched biographies at Gevo

• Paul Bloom, Chief Executive Officer, President and Director
• Andy Marsh, Director
• William Baum, Lead Independent Director

Popular executive movements at Gevo

• Joan Cetera has joined the company as Vice President of Communications and Public Relations  (posted on April 14 2026).
• Dave Kettner has joined the company as General Counsel  (posted on April 2 2026).
• Kyle James has joined the company as Chief Commercial Officer  (posted on April 2 2026).

Click here to view some more movements at Gevo

Create your alert
to follow the executive moves at Gevo.

Gevo has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Gevo

• Gevo Inc. - News
• Gevo Inc. - News
• Gevo Inc. - News
• Gevo Inc. - News
• Gevo Inc. - News
• Gevo Inc. - News
• Gevo Inc. - News
• https://investors.gevo.com/_resources/news/nr-2021-08-16.pdf
• Gevo Inc. - News
• Gevo Inc. - News
• View more press releases Close

Social media about Gevo

• Gevo on Wikipedia, Google News & Yahoo Finance
• Gevo on LinkedIn, X (Twitter) & YouTube